NIH Reporter #5R01HL163081-05

NIH Research Grant: Genotype-Guided Cardiometabolic Health Study at UAB

This opportunity is a research grant solicitation from the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health, for a genotype-guided study on cardiometabolic health at the University of Alabama at Birmingham. - Government Buyer: - National Heart Lung and Blood Institute (NHLBI), National Institutes of Health - Project Focus: - Research on the role of atrial natriuretic peptide in cardiometabolic health - Emphasis on genotype-guided human physiological studies - Investigation of genetic and molecular mechanisms influencing cardiometabolic health - Potential implications for RNA-based therapeutics - Location: - University of Alabama at Birmingham, Birmingham, AL - No specific OEMs, vendors, or product/service line items are mentioned in the notice - The opportunity is open for applications and is classified under microbiology and infectious disease research - Unique/Notable Requirements: - Focus on advanced genetic and molecular research - Potential for translational impact in RNA-based therapies

Description

This NIH grant opportunity focuses on a research project funded by the National Heart Lung and Blood Institute (NHLBI) at the University of Alabama at Birmingham. The study investigates genetic and molecular mechanisms affecting cardiometabolic health, with an emphasis on atrial natriuretic peptide and its regulation. The research aims to explore genotype-guided human physiological responses and has potential implications for RNA-based therapeutics development. The solicitation is open for applications with a response due date of June 19, 2026.

View original listing